No Picture
News

AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome

SAN DIEGO: SAN DIEGO, Feb. 3, 2022 /PRNewswire/ — The Aicardi-Goutières Syndrome Americas Association (AGSAA), LunaPBC, and Genetic Alliance today announced a program to assemble a patient-led drug discovery community studying the disease etiology of a rare neurodevelopmental disorder known as Aicardi-Goutières syndrome (AGS) and support development of therapeutic treatments… Click here to view original post… […]

No Picture
News

Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium™ 2022

CARMIEL, Israel: CARMIEL, Israel, Feb. 3, 2022 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that there will be two poster presentations… Click here to view original post… […]

No Picture
News

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

SAN DIEGO: SAN DIEGO, Feb. 3, 2022 /PRNewswire/ — Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profiling (CGP) in cancer therapy options in patients with late-stage disease compared to use… Click here to view original post… […]

No Picture
News

Wisdom Engendered: Study Finds Men and Women Have Different Strengths

Researchers looked at gender differences relative to wisdom, using two different validated scales and found that, in general, women scored higher on compassion-related items and on self-reflection while men scored higher on cognitive-related items and on emotional regulation. Click here to view original post… […]

No Picture
News

Halozyme Appoints New Chief Financial Officer

SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial officer, effective immediately. Ms. LaBrosse will succeed Elaine Sun, who is stepping down to pursue another opportunity. Ms. LaBrosse… Click here to view original post… […]

No Picture
News

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022

SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the fourth quarter and year-end 2021, after the market… Click here to view original post… […]

No Picture
News

Improving Care for Those Experiencing Traumatic Brain Injury Subject of New National Report

Tragically, almost 5 million people in the United States are evaluated in emergency departments for traumatic brain injury (TBI) each year. Over the past few decades, awareness of the magnitude and consequences of TBI has increased, particularly among athletes and military service members. Click here to view original post… […]

No Picture
News

CORTICA ADDS TWO PROVEN INDUSTRY LEADERS TO DRIVE NATIONWIDE GROWTH AND VALUE-BASED CARE

SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Cortica Inc. ("Cortica"), a high-growth, technology-enabled healthcare company, announced today the appointment of two new executives to bring Cortica’s "whole-child" medical and behavioral care model to more families across the country. Kari O’Rourke, MSN, NP-C joins Cortica as Chief Operating Officer,… Click here to view original post… […]

No Picture
News

Monarch Weather Consulting Launches Weather Intelligence GIS Content Solutions on Esri’s ArcGIS Marketplace

SAN DIEGO–(BUSINESS WIRE)–As the entrepreneurs behind Monarch Weather Consulting, meteorologists Crystal Egger and Kathryn Prociv create customized weather solution platforms that put real-time, actionable weather intelligence in their clients’ hands. A recent partnership announced with the Esri Startup Program will optimize Monarch’s ability to help clients from all industry sectors… Click here to view original post… […]

No Picture
News

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases with high unmet medical need, announced today that the Company and its collaborators Dr. Luc Furic, Head, Translational Prostate Cancer Research at Peter MacCallum… Click here to view original post… […]

No Picture
News

AARDVARK THERAPEUTICS, INC., ANNOUNCES THE INITIATION OF ENROLLMENT FOR THREE PHASE 2 CLINICAL TRIALS OF ORAL ARD-101

SAN DIEGO: SAN DIEGO, Feb. 2, 2022 /PRNewswire/ — Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing novel small molecule therapeutics for the treatment of metabolic and inflammatory diseases, announced today the initiation of enrollment in three Phase 2 studies with the company’s lead drug ARD-101, a… Click here to view original post… […]

No Picture
News

Oncolytics Biotech® Provides Positive Safety Update on the Pancreatic Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial

SAN DIEGO and CALGARY, AB: Independent safety review completed with no toxicity concerns Cohort builds on prior proof-of-concept data demonstrating clinical benefit of pelareorep-checkpoint inhibitor combination in pancreatic cancer Multi-indication trial being conducted in collaboration with Roche and AIO also includes cohorts in metastatic colorectal and advanced anal cancers SAN… Click here to view original post… […]

No Picture
News

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex® Technology and Intervention

CARLSBAD, Calif., and BRISBANE, Australia: CARLSBAD, Calif., and BRISBANE, Australia, Feb. 1, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to maximize patient health, today announced publication of results from the PREVENT trial showing that fewer breast cancer… Click here to view original post… […]

No Picture
News

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer, today announced that on January… Click here to view original post… […]

No Picture
News

Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has authorized the company’s investigational new drug (IND) application of DB104 (liafensine) for treatment-resistant depression (TRD) to proceed, which enables… Click here to view original post… […]

No Picture
News

NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective… Click here to view original post… […]

No Picture
News

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter fiscal year 2022, ended December 31, 2021, at 4:15 p.m. EST on… Click here to view original post… […]

No Picture
News

UK biotechs smash 2020 investment records, surpassing San Diego in VC and IPO raises

As stocks tumble amid a vicious biotech bear market, the UK has found something to celebrate: Last year, UK-based biotechs smashed the investment records they set in 2020, raising a mammoth $6.04 billion (£4.5 billion) in 2021 and surpassing San Diego in terms of venture and IPO funding. That’s a… Click here to view original post… […]

No Picture
News

REGENXBIO Announces Presentations at the 18th Annual WORLDSymposium™ 2022

ROCKVILLE, Md.: ROCKVILLE, Md., Jan. 31, 2022 /PRNewswire/ — Interim data from Phase I/II trials of RGX-121 for the treatment of MPS II and RGX-111 for the treatment of MPS I to be presentedREGENXBIO Inc. (Nasdaq: RGNX) today announced that five oral and seven poster presentations will be presented at… Click here to view original post… […]

No Picture
News

Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development

SAN DIEGO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–AlivaMab Discovery Sevices and Ablexis, have partnered with Almirall to discover new therapeutic antibodies for severe dermatological conditions. Click here to view original post… […]